Valensa Appoints Dr. Rudi E. Moerck President

May 23, 2006, 01:00 ET from Valensa International

    EUSTIS, Fla., May 23 /PRNewswire/ -- Valensa International has
 appointed Dr. Rudi E. Moerck as President. In his new role, Dr. Moerck will
 lead both the technology development and new product commercialization
 efforts for the company, which already offers innovative natural
 botanical-sourced products such as ZANTHIN(R) astaxanthin, USPlus Saw
 Palmetto, CRANBEROL(R) cranberry seed extract and more. In a career that
 spans more than 25 years, Dr. Moerck has held senior management positions
 in both the pharmaceutical and specialty chemical industries, as well as
 having research and commercial development experience. He holds patents in
 the areas of amino acid technology and nanotechnology and is the principal
 inventor of RenaZorb(TM), a new drug candidate for serum phosphate control
 in kidney dialysis patients with end stage renal disease.
     "The nutraceutical and botanical products industries are an important
 part of our culture and becoming increasingly more so -- as is evidenced by
 the growth of sectors like functional foods and cosmeceuticals," he said.
 "Ultimately, it will be our ability to deliver wellness to the consumer
 that will define our success -- and this will require creativity,
 scientific rigor, the right mix of technology and commercial acumen," he
     Prior to joining Valensa, Dr. Moerck was President of Altair
 Nanotechnologies. While at Altair, he was the principal inventor of
 RenaZorb(TM). RenaZorb(TM) was licensed by Spectrum Pharmaceuticals of
 Irvine, CA in January 2005. While at Altair, he was also the chief
 innovator of a new drug delivery system called TiNano Spheres(TM) for
 enhanced drug release or timed release for pharmaceuticals. His work in the
 pharmaceutical industry includes postings at Catalytica Pharmaceuticals as
 Sr. Vice President Sales and Marketing, V.P. and General Manager API
 manufacturing and R&D and also as President of the Fine Chemicals and
 Pharmaceuticals Group at Cambrex Corporation.
     Earlier in his career, Dr. Moerck worked at Degussa AG, a global
 chemicals and materials company where he held positions ranging from Senior
 Scientist and Pharmaceutical Plant Manager to Vice President where he was
 responsible for the development of Degussa's North American hydrogen
 peroxide business and the development of technology/services packages
 serving a wide range of industries.
     Dr. Moerck was awarded his Ph.D. in Organic Chemistry from the
 University of Florida and a Bachelor of Science degree in Biology from
 Florida Southern College. He received postdoctoral fellowships from both
 the National Science Foundation and the National Institutes of Health. Dr.
 Moerck taught pre- medical organic chemistry at Ohio State University and
 at Ohio Wesleyan University.
     About Valensa International
     Headquartered in Eustis, Florida, USA (near Orlando), Valensa
 International is a leading science-based developer and manufacturer of
 high- quality botanical sourced products for nutraceutical supplements,
 functional foods, human nutrition and cosmeceuticals. The Valensa
 organization is a leading supplier of two important ingredients --
 ZANTHIN(R) astaxanthin and USPlus(R) saw palmetto extract. In addition, the
 company markets a line of high value botanical extracts including
 CRANBEROL(R) cranberry seed oil, ginger, rosemary, oregano, and Valerex(R)
 valerian oils and oleoresins.
     For further information contact:
     Sid Hulse, Vice President, Marketing & Sales
     Voice: 352-357-2004 ext. 743
     Fax: 352-483-2095
     This release was issued through eReleases(TM). For more information,

SOURCE Valensa International